(IUSQ) iShares MSCI ACWI USD EUR - Ratings and Ratios
Stocks, Developed, Emerging, Large-Mid, Global
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 12.0% |
| Value at Risk 5%th | 19.2% |
| Relative Tail Risk | -2.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.14 |
| Alpha | -0.94 |
| CAGR/Max DD | 0.76 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.626 |
| Beta | 0.200 |
| Beta Downside | 0.407 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.25% |
| Mean DD | 2.52% |
| Median DD | 1.26% |
Description: IUSQ iShares MSCI ACWI USD EUR October 31, 2025
The iShares MSCI ACWI UCITS ETF USD (Acc) EUR (XETRA:IUSQ) tracks the Morningstar Global TME NR USD index, offering investors exposure to a diversified basket of large-cap equities across both developed and emerging markets. The fund is domiciled in Germany, classified under the Global Large-Cap Blend Equity category, and trades under the ticker IUSQ.
Key metrics (as of Q3 2025) include a total expense ratio of 0.20 % and assets under management of roughly $15 billion, making it one of the larger global equity ETFs. Its top ten holdings account for about 30 % of the portfolio, with Apple, Microsoft, Amazon, Alphabet, and Johnson & Johnson leading the list. Sector weighting is heavily tilted toward technology (≈ 25 % of assets) and financials (≈ 15 %), reflecting the continued dominance of these industries in global market capitalisation.
Performance drivers are tied to global macro-economic trends: sustained GDP growth in the United States and China, the trajectory of central-bank policy rates, and commodity price dynamics that affect emerging-market exposure. A recent shift toward higher-growth sectors such as cloud computing and renewable energy has modestly boosted the fund’s relative return versus its benchmark.
For a deeper quantitative breakdown and scenario analysis, you might explore the ValueRay platform to complement your due-diligence.
What is the price of IUSQ shares?
Over the past week, the price has changed by -1.33%, over one month by -1.70%, over three months by +3.53% and over the past year by +4.86%.
Is IUSQ a buy, sell or hold?
What are the forecasts/targets for the IUSQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 102.7 | 12% |
IUSQ Fundamental Data Overview December 11, 2025
Market Cap EUR = 12.81b (12.81b EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 12.81b EUR (12.81b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 12.81b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 12.81b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.75% (E(12.81b)/V(12.81b) * Re(6.75%) + (debt-free company))
Discount Rate = 6.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)